Drug‐target Mendelian randomization revealed a significant association of genetically proxied metformin effects with increased prostate cancer risk is a research paper published in Molecular Carcinogenesis (2024). On theSindex it has a DataRank of 0. It has been cited 7 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NCI NIH HHS
Grant: R00 CA230205
NCI NIH HHS
Grant: P30 CA008748
National Cancer Institute
FWCI
2.76
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals